Jump to content
Powered by

Latest news

Here you can find the latest articles about the Baden-Württemberg healthcare industry.

  • Article - 12/10/2015

    Thalidomide, which was sold in Germany in the late 1950s under the trade name Contergan, is mainly known for having caused one of the biggest pharmaceutical scandals in Germany. However, what was once a sleeping pill is increasingly being used as an immunomodulatory drug for treating tumours of the haematopoietic system, something that is not yet widely known. Dr. Jan Krönke is the head of a junior research group at Ulm University Hospital…

  • Article - 07/10/2015

    Modern genetic engineering tools enable genes to be modified in a genomic context in living cells. Genome surgery unlocks enormous potential for the treatment of genetic diseases, but it could also be misused for the uncontrolled manipulation of the human genome. An interdisciplinary working group of German scientists is calling for a moratorium on human germ line experiments to provide a space to define the opportunities and risks of this new…

  • Article - 05/10/2015

    Drops are a common way of applying drugs for treating a wide of range of eye diseases. Most of us have used eye drops at least once in our lives, but we are not usually aware that even if the drops are applied correctly, only one percent of the drug reaches the eye. The rest is flushed out by eyelid movement or with tear fluid. So very high drug concentrations are needed, and the downside of this is that it can cause substantial adverse effects.…

  • Article - 30/09/2015

    Very few people have ever heard of the chemical compound sulphoquinovose. This natural substance is nevertheless found in a large variety of foods. Sulphoquinovose has been playing an increasing role in cancer research, which is why demand for the compound is constantly growing. With this in mind, researchers from a company called MCAT GmbH from Konstanz are working on the development a method to synthesise larger quantities of sulphoquinovose…

  • Article - 28/09/2015

    It would be phenomenal news if it turned out that breast cancer could be detected by way of urine samples. Treating physicians would be able to use conspicuous test results to begin further examinations as quickly as possible along with therapy if necessary. Prof. Dr. Elmar Stickeler and his team from the Freiburg University Medical Centre have developed a method that identifies the composition of microRNAs in urine. They were able to predict…

  • Article - 24/09/2015

    The number of people suffering from oral or oropharyngeal cancer is rising steadily. The major cause of these cancers is human papillomaviruses (HPV) that colonise the oral cavity, where they are difficult to detect. QIAGEN Lake Constance GmbH from Stockach, in cooperation with Abviris Deutschland GmbH, has developed a new test system to improve the detection of oral HPV. This new system enables rapid and reliable quantitative detection of…

  • Article - 21/09/2015

    Nanoparticles are already used in many materials and areas, ranging from textiles to scientific and medical research. The global scientific community is keenly interested in nanoparticle research and Prof. Dr. Hans-Peter Deigner, professor in the Faculty of Medical and Life Sciences at Furtwangen University of Applied Sciences (HFU) is no exception. Deigner works on optimising nanoparticles for application in lateral flow assays. As well as…

  • Article - 21/09/2015

    The images of living cells that Venneos GmbH delivers are quite different from those captured by light microscopes. This is because the company, which was established in 2014, uses semi-conductors rather than optical lenses, thus opening up entirely new ways to analyse cells.

  • Article - 14/09/2015

    The cellular protein machinery is a marvel of nature and produces umpteen different proteins. Most of these proteins pass through a stack of membrane-enclosed discs, known as the Golgi apparatus, a miniature reaction chamber where the finishing touch is progressively added to the proteins. Rudolf Hausmann, professor and head of the Department of Bioprocess Engineering at the University of Hohenheim, is developing membranes based on the Golgi…

  • Article - 07/09/2015

    It was pure coincidence that Florian Lang chose the kidneys as his research object. Today, the physiologist from Tübingen is one of the most cited German kidney and hypertension specialists. Lang, who is 70 this year, mainly works with the regulation of ion channels and transporters in renal and other cells.

  • Article - 03/09/2015

    Dr. Patrick Müller explores cellular signalling pathways that turn undifferentiated cell clusters into orderly structures as embryos develop. Supported by an ERC grant, the Max Planck researcher from Tübingen uses a broad range of methods from the fields of genetics, biophysics, mathematics and the computer sciences for his investigations. Regenerative medicine is one field that particularly stands to benefit from Müller’s findings.

  • Article - 31/08/2015

    Dr. Günter Roth is head of the “Microarray Copying“ research group at the Center for Biological Systems Analysis (ZBSA) at the University of Freiburg. Roth, who studied physics and biochemistry, has developed a biomolecule copier that he plans to use to establish his own company. The company will be called BioCopy, and the planned product lines, AptaSWIFT and immune2day, have already won numerous prizes for Roth and his team. In an interview with…

Website address: https://www.gesundheitsindustrie-bw.de/en/article/news